Arrowhead Nets $9.6M Investment From U.K.-Based Silence Therapeutics

From Xconomy VC, Deals, & Startups
January 9, 2017 - 4:09pm
Silence Therapeutics, a publicly traded biotech firm based in the U.K., said it has made a $9.6 million equity investment in Arrowhead Pharmaceuticals. Silence said it acquired about 8.4 percent of the outstanding shares of common stock in Arrowhead (NASDAQ: ARWR), which is based in Pasadena, CA, but houses its research and development team in […]

Continue reading this article »